Cargando…

Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression

BACKGROUND: H3K27me3 histone marks shape the inhibition of gene transcription. In prostate cancer, the deregulation of H3K27me3 marks might play a role in prostate tumor progression. METHODS: We investigated genome-wide H3K27me3 histone methylation profile using chromatin immunoprecipitation (ChIP)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ngollo, Marjolaine, Lebert, Andre, Daures, Marine, Judes, Gaelle, Rifai, Khaldoun, Dubois, Lucas, Kemeny, Jean-Louis, Penault-Llorca, Frederique, Bignon, Yves-Jean, Guy, Laurent, Bernard-Gallon, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388998/ https://www.ncbi.nlm.nih.gov/pubmed/28403887 http://dx.doi.org/10.1186/s12885-017-3256-y

Ejemplares similares

The association between Histone 3 Lysine 27 Trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters
por: Ngollo, Marjolaine, et al.
Publicado: (2014)

SIRT1-dependent epigenetic regulation of H3 and H4 histone acetylation in human breast cancer
por: Rifaï, Khaldoun, et al.
Publicado: (2018)

A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2
por: Daures, Marine, et al.
Publicado: (2018)

Dual SIRT1 expression patterns strongly suggests its bivalent role in human breast cancer
por: Rifaï, Khaldoun, et al.
Publicado: (2017)

The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer
por: Karsli-Ceppioglu, Seher, et al.
Publicado: (2017)

Breaking down the Contradictory Roles of Histone Deacetylase SIRT1 in Human Breast Cancer
por: Rifaï, Khaldoun, et al.
Publicado: (2018)

The Functions of the Demethylase JMJD3 in Cancer
por: Sanchez, Anna, et al.
Publicado: (2021)

Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells
por: El Guerrab, Abderrahim, et al.
Publicado: (2020)

Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer
por: Guerrab, Abderrahim El, et al.
Publicado: (2016)

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
por: Fkih M’hamed, Insaf, et al.
Publicado: (2015)

Hypoxia increases genome-wide bivalent epigenetic marking by specific gain of H3K27me3
por: Prickaerts, Peggy, et al.
Publicado: (2016)

Cellular Expression of Cyclooxygenase, Aromatase, Adipokines, Inflammation and Cell Proliferation Markers in Breast Cancer Specimen
por: Basu, Samar, et al.
Publicado: (2015)

Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer
por: El Guerrab, Abderrahim, et al.
Publicado: (2017)

Antagonistic Roles for H3K36me3 and H3K27me3 in the Cold-Induced Epigenetic Switch at Arabidopsis FLC
por: Yang, Hongchun, et al.
Publicado: (2014)

Epigenetic engineering shows that a human centromere resists silencing mediated by H3K27me3/K9me3
por: Martins, Nuno M. C., et al.
Publicado: (2016)

Differential Impact of EGFR-Targeted Therapies on Hypoxia Responses: Implications for Treatment Sensitivity in Triple-Negative Metastatic Breast Cancer
por: El Guerrab, Abderrahim, et al.
Publicado: (2011)

Epigenetic drift of H3K27me3 in aging links glycolysis to healthy longevity in Drosophila
por: Ma, Zaijun, et al.
Publicado: (2018)

BRCA1 Induces Major Energetic Metabolism Reprogramming in Breast Cancer Cells
por: Privat, Maud, et al.
Publicado: (2014)

The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines
por: Dubois, Clémence, et al.
Publicado: (2019)

Epigenetic reprogramming of H3K27me3 and DNA methylation during leaf-to-callus transition in peach
por: Zheng, Beibei, et al.
Publicado: (2022)

EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer
por: Chinaranagari, Swathi, et al.
Publicado: (2014)

Contribution of the epigenetic mark H3K27me3 to functional divergence after whole genome duplication in Arabidopsis
por: Berke, Lidija, et al.
Publicado: (2012)

Genome-wide epigenetic cross-talk between DNA methylation and H3K27me3 in zebrafish embryos
por: de la Calle Mustienes, Elisa, et al.
Publicado: (2015)

Distribution of H3K27me3, H3K9me3, and H3K4me3 along autophagy-related genes highly expressed in starved zebrafish myotubes
por: Biga, Peggy R., et al.
Publicado: (2017)

c-Myc is Required for BRAF(V600E)-Induced Epigenetic Silencing by H3K27me3 in Tumorigenesis
por: Qu, Yiping, et al.
Publicado: (2017)

Targeting H3K27me3 loss in pediatric brain tumors - a perspective on epigenetically guided cancer therapy
por: Goldstein, Michael
Publicado: (2023)

The dynamic broad epigenetic (H3K4me3, H3K27ac) domain as a mark of essential genes
por: Beacon, Tasnim H., et al.
Publicado: (2021)

Systematic Analysis of Differential H3K27me3 and H3K4me3 Deposition in Callus and Seedling Reveals the Epigenetic Regulatory Mechanisms Involved in Callus Formation in Rice
por: Zhao, Nannan, et al.
Publicado: (2020)

PRC2 and EHMT1 regulate H3K27me2 and H3K27me3 establishment across the zygote genome
por: Meng, Tie-Gang, et al.
Publicado: (2020)

EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers
por: Au, Sandy Leung-Kuen, et al.
Publicado: (2013)

Flow-dependent epigenetic regulation of IGFBP5 expression by H3K27me3 contributes to endothelial anti-inflammatory effects
por: Xu, Suowen, et al.
Publicado: (2018)

PRC2 is required for extensive reorganization of H3K27me3 during epigenetic reprogramming in mouse fetal germ cells
por: Prokopuk, Lexie, et al.
Publicado: (2017)

The New Serum-Free OptiPASS(®) Medium in Cold and Oxygen-Free Conditions: An Innovative Conservation Method for the Preservation of MDA-MB-231 Triple Negative Breast Cancer Spheroids
por: Goisnard, Antoine, et al.
Publicado: (2021)

MeCP2 regulates gene expression through recognition of H3K27me3
por: Lee, Wooje, et al.
Publicado: (2020)

Nuc‐ErbB3 regulates H3K27me3 levels and HMT activity to establish epigenetic repression during peripheral myelination
por: Ness, Jennifer K., et al.
Publicado: (2016)

H3K27me3 at pericentromeric heterochromatin is a defining feature of the early mouse blastocyst
por: Pailles, Mélanie, et al.
Publicado: (2022)

Genomic imprinting of Xist by maternal H3K27me3
por: Inoue, Azusa, et al.
Publicado: (2017)

Targeted in vivo epigenome editing of H3K27me3
por: Fukushima, Hiroto S., et al.
Publicado: (2019)

Correction: EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers
por: Au, Sandy Leung-Kuen, et al.
Publicado: (2014)

PRDM14 controls X-chromosomal and global epigenetic reprogramming of H3K27me3 in migrating mouse primordial germ cells
por: Mallol, Anna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k39ne94fudrj4jae3iepiqs2g5